Strategic and insight-driven life sciences leader with over 13 years of experience driving data-enabled decision-making, market expansion, and commercial performance across biotech and pharmaceutical organizations. Adept at advising senior executives, leading high-performing teams, and shaping brand strategy through market modeling, forecasting, and real-world analytics. Trusted partner to top-tier clients, including Genentech, Amgen, Guardant Health, and Gilead Sciences.
Lead Axtria’s West Coast analytics practice, managing a 20-member team of data scientists and strategists. Serve as a strategic partner to senior pharma executives, driving enterprise-wide initiatives across market modeling, forecasting, patient analytics, and omnichannel strategy. Guide new market entry, launch planning, and data platform integration to support rare and specialty product commercialization. Influence key decisions on field deployment, targeting, and promotional investments.
Strategic Leadership and Commercial Impact
Analytics Innovation & Execution
Oversaw strategic analytics engagements across neuroscience and rare disease portfolios. Built and led a 10-member team supporting business-critical analytics across patient insights, forecasting, segmentation, and marketing performance.
Directed strategic analytics and commercial transformation projects for the U.S. Pharma clients. Engaged VP-level stakeholders to shape brand strategy, enhance customer engagement, and optimize execution.